Veradigm (NASDAQ:MDRX) Sees Large Volume Increase – Should You Buy?

Shares of Veradigm Inc. (NASDAQ:MDRXGet Free Report) saw unusually-strong trading volume on Thursday . Approximately 2,745,862 shares changed hands during trading, an increase of 767% from the previous session’s volume of 316,544 shares.The stock last traded at $4.90 and had previously closed at $4.60.

Veradigm Price Performance

The company has a fifty day moving average of $4.76 and a two-hundred day moving average of $4.75. The stock has a market capitalization of $536.33 million, a P/E ratio of 23.25 and a beta of 0.51.

About Veradigm

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Recommended Stories

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.